RE:RE:RE:Will Sebastiens 400 M sales come true??No two companies within the same sector will be exactly the same therefore investors need a means to compares companies with the most similarities to one another based on sales vs their sharecounts. The PS-Ratio method provides this means of comparison.
Considering Canopy Growth and HEXO line up in sumilarites in the following ways the companies are comparible;
- Both have major alchole backers, HEXO has Molson, Canopy has Constellation Brands.
- Both provide medical and rec products
- Both provide Cannabis 2.0 products such as drinks and vapes
- Both are expanding operations overseas and making moves into the US
- Both are seeking to raise capital, HEXO at 1.2 Billion, Canopy at 2.0 Billion
The market will se the price to sales ratio based on sectors, some sectors have higher PS-Ratios while others will have lowers, to say one ratio is right and another is wrong is ignorant as the market decides stock prices, not the opinion of individual traders.
Canopy trades at a substantially higher PS-Ratio than HEXO while HEXO is a very comparible company based on product offerings, markets being accessed and recent moves of both organizations.
Link to PS-Ratio Data for HEXO with Canopy as a Comparison https://ycharts.com/companies/HEXO.TO/ps_ratio
Knowledge is Power, do your own research and give yourself some power
GLTA
Q
quinlash wrote: If you care to take the time to learn about Price to Sales Ratio comparisons you will be able to compare the ratio that Canopy Growth Stocks trade for compared to HEXO. If you think reverse calculate the price of HEXO shares at the Canopy Growth PS-Ratio you will find that the HEXO shares will trade well over $20 at the same ratio.
If you then carry in the additional sales number from Zenabis and 48-North the share-price moves even higher.
PS ratio math does not provide a schedule as to when this will happen however it does provide a means for investors to determine the upside potential of a shareprice.... regardless if you trade short or long.
GLTA
Enjoy your weekend
Q
quinlash wrote: if we look at the last QTR report from HEXO, Zenabis and 48-North, add those numbers up and multiple it by 4 we can get a starting point for what the annual sales numbers will start coming in once the new acquistions are rolled up under the HEXO banner
| HEXO | Zenabis | 48-North | Totals | Extended for 1 Year |
| $45,678,000 | $24,812,000 | $7,607,000 | $78,097,000 | $312,388,000 |
| $41,300,000 | $28,490,000 | $6,713,000 | $76,503,000 | |
| $36,100,000 | $30,280,000 | $10,472,000 | $76,852,000 | |
| $30,900,000 | $22,361,000 | $2,806,000 | $56,067,000 | |
At a QTR over QTR average rate of growth of 8% HEXO will require no more than 3 additional QTRs to come in over the 400 million dollars in sales per QTR. If the growth rate goes up due to the company expanding into new markets, the rolling out of new products or HEXO pulls in another smaller company, then the target of $400 becomes reality in less time.
All the best
Q
quebec4ever wrote: He was just too early at the party in 2019.......but it seems as if we re going to hit it with our recent acquisitions:) This guy is a true visionary .......and the courage to pursue it ! Congrats to you and the whole team !